Dosing instructions for IV paracetamol simplified

on the 14 March 2014

The dosing instructions for the intravenous paracetamol product Perfalgan are now based solely on body weight regardless of the patient's age.

Perfalgan is indicated for the short-term treatment of moderate pain (especially following surgery) and fever. | SCIENCE PHOTO LIBRARY
Perfalgan is indicated for the short-term treatment of moderate pain (especially following surgery) and fever. | SCIENCE PHOTO LIBRARY

The revised Summary of Product Characteristics for Perfalgan provides a recommended dose for both adults and children according to four different weight bands: <10kg; >10kg to <33kg; >33kg to <50kg; and >50kg. For the >50kg weight band the recommended maximum daily dose is dependent on the presence or absence of additional risk factors for hepatotoxicity.

Doses are presented in both milligrams per kilogram and millilitres per kilogram with a recommendation that prescribers state the total dose in both milligrams and volume to avoid dosing errors.

View Perfalgan drug record

Further information: Bristol-Myers Squibb

Follow MIMS on Twitter

Sign up for MIMS bulletins
Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

The most up-to-date drug information at your fingertips.

  • Get the prescribing support you need.
  • Register today for full access to the MIMS database, plus tables and guideline summaries, new and deleted products and consultation tools.
Register Now
Already Registered?

Forgotten password?

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Twitter  

More from MIMS

MHRA restricts indications for quinolone antibiotics following EU-wide safety review

MHRA restricts indications for quinolone antibiotics following EU-wide safety review

New restrictions and precautions for use have been...

Emollients, Potential Skin Sensitisers as Ingredients

Emollients, Potential Skin Sensitisers as Ingredients

Potential sensitising agents in emollient preparations.

Ophthalmic Preparations, Preservatives and Potential Sensitisers as Ingredients

Ophthalmic Preparations, Preservatives and Potential Sensitisers as Ingredients

Potential sensitising agents in eye drops and ointments.

Anti-Anginal Preparations, Summary by Pharmacological Class

Anti-Anginal Preparations, Summary by Pharmacological Class

Available formulations of anti-anginal drugs.